| JXSS1900050 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900048 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900047 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| CXSS2000021 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2020-05-29 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2021-11-05 | view |
| CXSS1900039 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2019-11-08 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-09-08 | view |
| CYSB2100038 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-23 | 同路生物制药有限公司 | Tonrol Bio-Pharmaceutical Co Limited | Certificate Issued | 2021-08-19 | view |
| CYSB2100039 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-23 | 同路生物制药有限公司 | Tonrol Bio-Pharmaceutical Co Limited | Certificate Issued | 2021-08-19 | view |
| JXSS1900051 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-17 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-08-11 | view |
| JXSS1900052 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-16 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-08-11 | view |
| CXSS1900042 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
| CXSS1900043 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
| CXSL2100090 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2021-03-12 | 河北大安制药有限公司 | Bohui Biopharmaceutical (Hebei) Co Ltd | In Review | 2021-03-12 | view |
| JYSB2000595 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-14 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2000598 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-16 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2000597 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-16 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2000596 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-14 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2100025 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
| JYSB2100024 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
| JYSB2100027 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
